Inventiva (IVA) Debt to Equity (2018 - 2025)
Inventiva (IVA) recorded quarterly Debt to Equity of -$5.8 in Q2 2025, up 98.73% quarter-over-quarter from -$454.82 in Q4 2024, and down 1309710.29% on a YoY basis from N/an in Q2 2024.
Inventiva (IVA) Debt to Equity (2018 - 2025) Analysis & Trends
Inventiva's Debt to Equity history runs 8 years deep, the most recent figure standing at -$5.8 for Q2 2025.
- In Q2 2025, Debt to Equity fell 1309710.29% year-over-year to -$5.8; the TTM figure through Jun 2025 stood at -$5.8 (down 1309710.29% YoY), while the FY2024 annual figure was -$454.82, down 53449.94% from the prior year.
- Debt to Equity was -$5.8 for Q2 2025 at Inventiva, up from -$454.82 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $1.28 in Q4 2022 to a low of -$454.82 in Q4 2024.
- Historically, Debt to Equity has averaged -$57.5 across 5 years, with a median of $0.0 in 2023.
- The sharpest annual moves came in 2022 and 2025: Debt to Equity surged 1026.86% in 2022, then sank 1309710.29% in 2025.
- A 5-year view of Debt to Equity shows it stood at $0.11 in 2021, then soared by 1026.86% to $1.28 in 2022, then plunged by 166.19% to -$0.85 in 2023, then tumbled by 53449.94% to -$454.82 in 2024, then jumped by 98.73% to -$5.8 in 2025.
- The last three Debt to Equity figures came in at -$5.8 (Q2 2025), -$454.82 (Q4 2024), and $0.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 0.32 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -5.80 |
| Dec 31, 2024 | -454.82 |
| Jun 30, 2024 | 0.00 |
| Dec 31, 2023 | -0.85 |
| Jun 30, 2023 | 0.00 |
| Dec 31, 2022 | 1.28 |
| Dec 31, 2021 | 0.11 |
| Mar 31, 2021 | 0.10 |
| Dec 31, 2020 | 0.09 |
| Dec 31, 2019 | 0.00 |
| Dec 31, 2018 | 0.00 |